Tarsus Pharmaceuticals
TARS
TARS
105 hedge funds and large institutions have $529M invested in Tarsus Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 49 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
105
Holders Change
+13
Holders Change %
+14.13%
% of All Funds
1.67%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
25
Increased
49
Reduced
13
Closed
12
Calls
$577K
Puts
$308K
Net Calls
+$269K
Net Calls Change
+$7K
Top Buyers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$46.6M |
| 2 |
TCM
TCG Crossover Management
Palo Alto,
California
|
$20.3M |
| 3 |
DM
Deerfield Management
New York
|
$13.4M |
| 4 |
Millennium Management
New York
|
$14.4M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
$9.21M |
